REMOVAL OF VIRUCIDAL AGENTS IN MIXED MODE CHROMATOGRAPHY
    232.
    发明申请
    REMOVAL OF VIRUCIDAL AGENTS IN MIXED MODE CHROMATOGRAPHY 审中-公开
    在混合模式色谱中去除VIRUCIDAL代理

    公开(公告)号:US20130109807A1

    公开(公告)日:2013-05-02

    申请号:US13654802

    申请日:2012-10-18

    Inventor: Peter S. GAGNON

    CPC classification number: C07K16/065

    Abstract: The present invention provides chromatography methods for removing a virucidal agent from a target protein such as an antibody. The method uses a hydrophobic, negatively charged mixed mode support that has high affinity for both the target protein and the virucidal agent. The method provides conditions that favor dissociation of the virucidal agent from the protein, allowing the virucidal agent to bind strongly to the support. The target protein is then eluted from the support under conditions such that the virucidal agent remains bound to the support.

    Abstract translation: 本发明提供了从靶蛋白如抗体中除去杀病毒剂的层析方法。 该方法使用对靶蛋白和杀病毒剂具有高亲和力的疏水性带负电荷的混合模式载体。 该方法提供有利于从杀虫剂与蛋白质解离的条件,使得杀病毒剂与载体强烈结合。 然后在使得杀病毒剂保持与载体结合的条件下从载体上洗脱靶蛋白质。

    Vaccum manifold for both multi-well plate and individual columns
    233.
    发明申请
    Vaccum manifold for both multi-well plate and individual columns 审中-公开
    用于多孔板和单柱的Vaccum歧管

    公开(公告)号:US20040258575A1

    公开(公告)日:2004-12-23

    申请号:US10885938

    申请日:2004-07-06

    Inventor: Brian A. Perry

    Abstract: An adapter plate transforms a vacuum manifold designed for standard multi-well plates that are commonly used in biochemical laboratories into one that can be used for columns such as chromatographic columns, filtration columns, and the like. The plate contains an array of male-female-type complementary connectors, each connector fitted with a removable plug that seals the connector off when not in use. The plate thus allows the manifold to be used for as few as one column or any number up to the total number of connectors in the plate.

    Abstract translation: 适配器板将设计用于生物化学实验室通常使用的标准多孔板的真空歧管转换成可用于色谱柱,过滤柱等柱。 该板包含一个阳 - 阴型互补连接器阵列,每个连接器都配有可拆卸的插头,用于在不使用时将连接器密封。 因此,该板允许歧管用于少至一列或任何数量,直到板中的连接器总数。

    Tube rack accommodating a range of tube diameters
    234.
    发明申请
    Tube rack accommodating a range of tube diameters 有权
    管架容纳一定范围的管直径

    公开(公告)号:US20040195193A1

    公开(公告)日:2004-10-07

    申请号:US10408758

    申请日:2003-04-03

    CPC classification number: B01L9/06 B01L2200/025

    Abstract: A tube rack for holding and transporting sample tubes or other liquids in an automated analyzer is built to accommodate tubes of different sizes in a stable aligned configuration, the rack containing a row of parallel open-top tube chambers, each chamber containing two sets of resilient tabs integrally molded with the chamber walls and at different heights in the chamber.

    Abstract translation: 用于在自动分析器中保持和运送样品管或其他液体的管架被构建成容纳具有稳定对准构型的不同尺寸的管,该架包含一排平行的开放式顶管管腔,每个室包含两组弹性 与室壁整体成型并且在室中的不同高度处的突片。

    Multiplex flow assays preferably with magnetic particles as solid phase
    235.
    发明申请
    Multiplex flow assays preferably with magnetic particles as solid phase 有权
    多重流动分析优选用磁性颗粒作为固相

    公开(公告)号:US20040126904A1

    公开(公告)日:2004-07-01

    申请号:US10734957

    申请日:2003-12-11

    Abstract: Heterogeneous assays for different analytes in a single biological sample are performed simultaneously in a multiplexed assay that combines flow cytometry with the use of magnetic particles as the solid phase and yields an individual result for each analyte. The particles are distinguishable from each other by characteristics that permit them to be differentiated into groups, each group carrying an assay reagent bonded to the particle surface that is distinct from the assay reagents of particles in other groups. The magnetic particles facilitate separation of the solid and liquid phases, permitting the assays to be performed by automated equipment. Assays are also disclosed for the simultaneous detection of antibodies of different classes and a common antigen specificity or of a common class and different antigen specificities. Each type is accomplished by immunological binding at the surfaces of two distinct solid phases in a sequential manner with dissociation of the binding and washing of the solid phase in between the binding steps.

    Abstract translation: 在单一生物样品中的不同分析物的非均相测定在多重测定中同时进行,其结合流式细胞术和使用磁性颗粒作为固相,并为每种分析物产生单独的结果。 颗粒可通过允许将其分成组的特征彼此区分,每个组携带与颗粒表面结合的测定试剂,其不同于其它组中的颗粒的测定试剂。 磁性颗粒促进固相和液相的分离,允许通过自动化设备进行测定。 还公开了用于同时检测不同类型的抗体和共同抗原特异性或共同类别和不同抗原特异性的测定。 每种类型通过在两个不同的固相的表面之间的顺序方式通过在结合步骤之间的结合和洗涤固相的解离来实现。

    Universal signal amplification tail
    236.
    发明申请
    Universal signal amplification tail 审中-公开
    通用信号放大尾

    公开(公告)号:US20040002095A1

    公开(公告)日:2004-01-01

    申请号:US10394492

    申请日:2003-03-20

    CPC classification number: C12Q1/682 C12Q2525/161 C12Q2525/151 C12Q2563/179

    Abstract: The present invention resides in a detection agent that can be used to amplify a detection signal for a target molecule. The detection agent contains a linear first single-stranded nucleic acid attached to a capture moiety that specific binds the target molecule of interest. The first single-stranded nucleic acid includes a plurality of repeat sequences, each of which is non-homopolymeric and can specifically bind to a second single-stranded nucleic acid that has at least one detectable label. Related method for using the claimed detection agent to amplify a detection signal and a kit for this purpose are also disclosed.

    Abstract translation: 本发明涉及可用于放大靶分子检测信号的检测剂。 检测剂含有连接到特异性结合感兴趣的靶分子的捕获部分的线性第一单链核酸。 第一单链核酸包括多个重复序列,每个重复序列均为非均聚物并且可以特异性结合至少具有至少一个可检测标记的第二单链核酸。 还公开了使用所要求保护的检测剂放大检测信号的相关方法和用于此目的的试剂盒。

    Nucleic acid derivatives
    237.
    发明申请
    Nucleic acid derivatives 有权
    核酸衍生物

    公开(公告)号:US20030191074A1

    公开(公告)日:2003-10-09

    申请号:US10057928

    申请日:2002-01-29

    Inventor: David Segev

    Abstract: A compound which comprises a backbone having a plurality of chiral carbon atoms, the backbone bearing a plurality of ligands each being individually bound to a chiral carbon atom of the plurality of chiral carbon atoms, the ligands including one or more pair(s) of adjacent ligands each containing a moiety selected from the group consisting of a naturally occurring nucleobase and a nucleobase binding group, wherein moieties of the one or more pair(s) are directly linked to one another via a linker chain; building blocks for synthesizing the compound; and rises of the compound, particularly in antisense therapy.

    Abstract translation: 包含具有多个手性碳原子的骨架的化合物,所述骨架具有多个配体,每个配体各自与多个手性碳原子的手性碳原子结合,所述配体包括一个或多个相邻的一对 各自含有选自天然存在的核碱基和核碱基结合基团的部分的配体,其中所述一个或多个对的部分通过连接体链彼此直接连接; 用于合成化合物的结构单元; 化合物的升高,特别是在反义治疗中。

    FXIII detection for verifying serum sample and sample size and for detecting dilution

    公开(公告)号:US20030113801A1

    公开(公告)日:2003-06-19

    申请号:US10263436

    申请日:2002-10-01

    CPC classification number: G01N33/96 G01N2333/9108 Y10S435/973

    Abstract: Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.

Patent Agency Ranking